Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies. Its mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development. 

Huntington, US
Size (employees)
11 (est)+10%
Envisagenics was founded in 2014 and is headquartered in Huntington, US
Report incorrect company information

Envisagenics Office Locations

Envisagenics has an office in Huntington
Show all (1)
Report incorrect company information

Envisagenics Financials and Metrics

Summary Metrics

Envisagenics's latest funding round in November 2017 was reported to be $2.4 m. In total, Envisagenics has raised $3.1 m
Report incorrect company information